| [20] |
Penno G,Solini A,Bonora E, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes[J]. J Hypertens, 2011, 29(9): 1802-1809.
|
| [21] |
Kramer HJ,Nguyen QD,Curhan G, et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus[J]. JAMA, 2003, 289(24): 3273-3277.
|
| [22] |
Penno G,Solini A,Zoppini G, et al. Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study[J]. Diabetes Care, 2012, 35(11): 2317-2323.
|
| [23] |
New JP,Middleton RJ,Klebe B, et al. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice[J]. Diabet Med, 2007, 24(4): 364-369.
|
| [24] |
Boronat M,Garcia-Canton C,Quevedo V, et al. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus[J]. Ren Fail, 2014, 36(2): 166-170.
|
| [25] |
Araki S,Haneda M,Sugimoto T, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes[J]. Diabetes, 2005, 54(10): 2983-2987.
|
| [26] |
Molitch ME,Steffes M,Sun W, et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study[J]. Diabetes Care, 2010, 33(7): 1536-1543.
|
| [27] |
Lane PH,Steffes MW,Mauer SM. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion[J]. Diabetes, 1992, 41(5): 581-586.
|
| [28] |
De Cosmo S,Lamacchia O,Pacilli A, et al. Normoalbuminuric renal impairment and all-cause mortality in type 2 diabetes mellitus[J]. Acta Diabetol, 2014, 51(4): 687-689.
|
| [29] |
Kamijo-Ikemori A,Sugaya T,Yasuda T, et al. Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients[J]. Diabetes Care, 2011, 34(3): 691-696.
|
| [30] |
Shimizu M,Furuichi K,Yokoyama H, et al. Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency[J]. Clin Exp Nephrol, 2014, 18(2): 305-312.
|
| [31] |
Araki S,Haneda M,Sugimoto T, et al. Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria[J]. Diabetes Care, 2006, 29(4): 864-868.
|
| [32] |
MacIsaac RJ,Panagiotopoulos S,McNeil KJ, et al. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?[J]. Diabetes Care, 2006, 29(7): 1560-1566.
|
| [33] |
Mattock MB,Barnes DJ,Viberti G, et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study[J]. Diabetes, 1998, 47(11): 1786-1792.
|
| [34] |
Yagil C,Barak A,Ben-Dor D, et al. Nonproteinuric diabetes-associated nephropathy in the Cohen rat model of type 2 diabetes[J]. Diabetes, 2005, 54(5): 1487-1496.
|
| [35] |
Ekinci EI,Jerums G,Skene A, et al. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function[J]. Diabetes Care, 2013, 36(11): 3620-3626.
|
| [36] |
An JH,Cho YM,Yu HG, et al. The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication[J]. J Korean Med Sci, 2009, 24 Suppl: S75-S81.
|
| [37] |
Ruggenenti P,Fassi A,Ilieva AP, et al. Preventing microalbuminuria in type 2 diabetes[J]. N Engl J Med, 2004, 351(19): 1941-1951.
|
| [38] |
Porrini E,Ruggenenti P,Mogensen CE, et al. Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes[J]. Lancet Diabetes Endocrinol, 2015, 3(5): 382-391.
|
| [39] |
Neugarten J,Acharya A,Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis[J]. J Am Soc Nephrol, 2000, 11(2): 319-329.
|
| [40] |
Sun L,Kanwar YS. Relevance of TNF-alpha in the context of other inflammatory cytokines in the progression of diabetic nephropathy[J]. Kidney Int, 2015, 88(4): 662-665.
|
| [41] |
Perkins BA,Krolewski AS. Early nephropathy in type 1 diabetes: the importance of early renal function decline[J]. Curr Opin Nephrol Hypertens, 2009, 18(3): 233-240.
|
| [42] |
Niewczas MA,Ficociello LH,Johnson AC, et al. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes[J]. Clin J Am Soc Nephrol, 2009, 4(1): 62-70.
|
| [43] |
Onuigbo MA. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD[J]. Ren Fail, 2010, 32(8): 954-958.
|
| [44] |
Onuigbo MA,Agbasi N. Diabetic nephropathy and CKD-analysis of individual patient serum creatinine trajectories: a forgotten diagnostic methodology for diabetic CKD prognostication and prediction[J]. J Clin Med, 2015, 4(7): 1348-1368.
|
| [45] |
Shimizu M,Furuichi K,Toyama T, et al. Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy[J]. Diabetes Care, 2013, 36(11): 3655-3662.
|
| [46] |
Perkins BA,Ficociello LH,Ostrander BE, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes[J]. J Am Soc Nephrol, 2007, 18(4): 1353-1361.
|
| [47] |
Ruggenenti P,Porrini E,Motterlini N, et al. Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes[J]. J Am Soc Nephrol, 2012, 23(10): 1717-1724.
|
| [48] |
Levey AS,Cattran D,Friedman A, et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration[J]. Am J Kidney Dis, 2009, 54(2): 205-226.
|
| [49] |
Penno G,Solini A,Zoppini G, et al. Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study[J]. Acta Diabetol, 2015, 52(5): 971-981.
|
| [1] |
Xiao L,Wang M,Yang S, et al. A glimpse of the pathogenetic mechanisms of Wnt/beta-catenin signaling in diabetic nephropathy[J]. Biomed Res Int, 2013, 2013: 987064.
|
| [2] |
Kwak SH,Park KS. Genetic studies on diabetic microvascular complications: focusing on genome-wide association studies[J]. Endocrinol Metab (Seoul), 2015, 30(2): 147-158.
|
| [3] |
Xu X,Xiao L,Xiao P, et al. A glimpse of matrix metalloproteinases in diabetic nephropathy[J]. Curr Med Chem, 2014, 21(28): 3244-3260.
|
| [50] |
de Carvalho JA,Tatsch E,Hausen BS, et al. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes[J]. Clin Biochem, 2016, 49(3): 232-236.
|
| [51] |
Alter ML,Kretschmer A,Von Websky K, et al. Early urinary and plasma biomarkers for experimental diabetic nephropathy[J]. Clin Lab, 2012, 58(7-8): 659-671.
|
| [52] |
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-S266.
|
| [4] |
KDOQI Work Group. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease[J]. Am J Kidney Dis, 2007, 49(2 Suppl 2): S12-S154.
|
| [5] |
Giordano AL,Siegel HI,Rosenblatt JS. Nuclear estrogen receptor binding in the preoptic area and hypothalamus of pregnancy-terminated rats: correlation with the onset of maternal behavior[J]. Neuroendocrinology, 1989, 50(3): 248-258.
|
| [6] |
Tsalamandris C,Allen TJ,Gilbert RE, et al. Progressive decline in renal function in diabetic patients with and without albuminuria[J]. Diabetes, 1994, 43(5): 649-655.
|
| [53] |
Levey AS,Bosch JP,Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group[J]. Ann Intern Med, 1999, 130(6): 461-470.
|
| [54] |
Cockcroft DW,Gault MH. Prediction of creatinine clearance from serum creatinine[J]. Nephron, 1976, 16(1): 31-41.
|
| [55] |
Caramori ML,Fioretto P,Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions[J]. Diabetes, 2003, 52(4): 1036-1040.
|
| [56] |
Brenner BM,Cooper ME,de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy[J]. N Engl J Med, 2001, 345(12): 861-869.
|
| [57] |
Lewis EJ,Hunsicker LG,Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J]. N Engl J Med, 2001, 345(12): 851-860.
|
| [58] |
Satirapoj B,Kaewput W,Supasyndh O, et al. Effect of sulodexide on urinary biomarkers of kidney injury in normoalbuminuric type 2 diabetes: a randomized controlled trial[J]. J Diabetes Res, 2015, 2015: 172038.
|
| [7] |
MacIsaac RJ,Tsalamandris C,Panagiotopoulos S, et al. Nonalbuminuric renal insufficiency in type 2 diabetes[J]. Diabetes Care, 2004, 27(1): 195-200.
|
| [8] |
Lacquaniti A,Donato V,Pintaudi B, et al. " Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL[J]. Acta Diabetol, 2013, 50(6): 935-942.
|
| [9] |
Mottl AK,Kwon KS,Mauer M, et al. Normoalbuminuric diabetic kidney disease in the U. S. population[J]. J Diabetes Complications, 2013, 27(2): 123-127.
|
| [10] |
Macisaac RJ,Jerums G. Diabetic kidney disease with and without albuminuria[J]. Curr Opin Nephrol Hypertens, 2011, 20(3): 246-257.
|
| [11] |
American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers[J]. Clin Diabetes, 2015, 33(2): 97-111.
|
| [12] |
Zelmanovitz T,Gross JL,Oliveira JR, et al. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy[J]. Diabetes Care, 1997, 20(4): 516-519.
|
| [13] |
Dwyer JP,Parving HH,Hunsicker LG, et al. Renal Dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND Study[J]. Cardiorenal Med, 2012, 2(1): 1-10.
|
| [14] |
Kramer CK,Leitao CB,Pinto LC, et al. Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria[J]. Diabetes Care, 2007, 30(8): 1998-2000.
|
| [15] |
Bhalla V,Zhao B,Azar KM, et al. Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease[J]. Diabetes Care, 2013, 36(5): 1215-1221.
|
| [59] |
Nielsen SE,Reinhard H,Zdunek D, et al. Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients[J]. Diabetes Res Clin Pract, 2012, 97(1): 71-76.
|
| [60] |
Dwyer JP,Lewis JB. Nonproteinuric diabetic nephropathy: when diabetics don't read the textbook[J]. Med Clin North Am, 2013, 97(1): 53-58.
|
| [16] |
Rigalleau V,Lasseur C,Raffaitin C, et al. Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group[J]. Diabetes Care, 2007, 30(8): 2034-2039.
|
| [17] |
Retnakaran R,Cull CA,Thorne KI, et al. Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74[J]. Diabetes, 2006, 55(6): 1832-1839.
|
| [18] |
Yokoyama H,Sone H,Oishi M, et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15)[J]. Nephrol Dial Transplant, 2009, 24(4): 1212-1219.
|
| [19] |
Thomas MC,Macisaac RJ,Jerums G, et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON]11)[J]. Diabetes Care, 2009, 32(8): 1497-1502.
|